350 related articles for article (PubMed ID: 33114183)
41. Mechanistic basis and clinical relevance of the role of transforming growth factor-β in cancer.
Lin RL; Zhao LJ
Cancer Biol Med; 2015 Dec; 12(4):385-93. PubMed ID: 26779375
[TBL] [Abstract][Full Text] [Related]
42. Transforming growth factor-β signalling in renal fibrosis: from Smads to non-coding RNAs.
Tang PM; Zhang YY; Mak TS; Tang PC; Huang XR; Lan HY
J Physiol; 2018 Aug; 596(16):3493-3503. PubMed ID: 29781524
[TBL] [Abstract][Full Text] [Related]
43. Extracellular Hsp90 and TGFβ regulate adhesion, migration and anchorage independent growth in a paired colon cancer cell line model.
de la Mare JA; Jurgens T; Edkins AL
BMC Cancer; 2017 Mar; 17(1):202. PubMed ID: 28302086
[TBL] [Abstract][Full Text] [Related]
44. Transforming growth factor-beta (TGF-beta).
Clark DA; Coker R
Int J Biochem Cell Biol; 1998 Mar; 30(3):293-8. PubMed ID: 9611771
[TBL] [Abstract][Full Text] [Related]
45. TNF-α enhances TGF-β-induced endothelial-to-mesenchymal transition via TGF-β signal augmentation.
Yoshimatsu Y; Wakabayashi I; Kimuro S; Takahashi N; Takahashi K; Kobayashi M; Maishi N; Podyma-Inoue KA; Hida K; Miyazono K; Watabe T
Cancer Sci; 2020 Jul; 111(7):2385-2399. PubMed ID: 32385953
[TBL] [Abstract][Full Text] [Related]
46. Transforming growth factor-β1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice.
Zhang Y; Meng XM; Huang XR; Wang XJ; Yang L; Lan HY
Clin Exp Pharmacol Physiol; 2014 Nov; 41(11):921-32. PubMed ID: 25132073
[TBL] [Abstract][Full Text] [Related]
47. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
Tian H; Liu J; Chen J; Gatza ML; Blobe GC
Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
[TBL] [Abstract][Full Text] [Related]
48. TGF-betal/Smad signaling in prostate cancer.
Bello-DeOcampo D; Tindall DJ
Curr Drug Targets; 2003 Apr; 4(3):197-207. PubMed ID: 12643470
[TBL] [Abstract][Full Text] [Related]
49. Scientific reports concerning the impact of interleukin 4, interleukin 10 and transforming growth factor β on cancer cells.
Kwaśniak K; Czarnik-Kwaśniak J; Maziarz A; Aebisher D; Zielińska K; Karczmarek-Borowska B; Tabarkiewicz J
Cent Eur J Immunol; 2019; 44(2):190-200. PubMed ID: 31530989
[TBL] [Abstract][Full Text] [Related]
50. Novel patents and cancer therapies for transforming growth factor-beta and urokinase type plasminogen activator: potential use of their interplay in tumorigenesis.
Krstic J; Maslovaric I; Santibanez JF
Recent Pat Anticancer Drug Discov; 2014; 9(3):354-71. PubMed ID: 24827562
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA Control of TGF-β Signaling.
Suzuki HI
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29958433
[TBL] [Abstract][Full Text] [Related]
52. Role of transforming growth factor-beta in cancer progression.
Galliher AJ; Neil JR; Schiemann WP
Future Oncol; 2006 Dec; 2(6):743-63. PubMed ID: 17155901
[TBL] [Abstract][Full Text] [Related]
53. Transforming growth factor-beta, cell signaling and cardiovascular disorders.
Agrotis A; Kalinina N; Bobik A
Curr Vasc Pharmacol; 2005 Jan; 3(1):55-61. PubMed ID: 15638782
[TBL] [Abstract][Full Text] [Related]
54. TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?
Muñoz-Félix JM; González-Núñez M; Martínez-Salgado C; López-Novoa JM
Pharmacol Ther; 2015 Dec; 156():44-58. PubMed ID: 26493350
[TBL] [Abstract][Full Text] [Related]
55. The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.
Imamura T; Hikita A; Inoue Y
Breast Cancer; 2012 Apr; 19(2):118-24. PubMed ID: 22139728
[TBL] [Abstract][Full Text] [Related]
56. TGF-β and Hepatocellular Carcinoma: When A Friend Becomes An Enemy.
Arrese M; Hernandez A; Astete L; Estrada L; Cabello-Verrugio C; Cabrera D
Curr Protein Pept Sci; 2018; 19(12):1172-1179. PubMed ID: 29150921
[TBL] [Abstract][Full Text] [Related]
57. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
58. TGF-β-activated kinase-1: New insights into the mechanism of TGF-β signaling and kidney disease.
Kim SI; Choi ME
Kidney Res Clin Pract; 2012 Jun; 31(2):94-105. PubMed ID: 26889415
[TBL] [Abstract][Full Text] [Related]
59. Transforming growth factor-beta and fibrosis.
Verrecchia F; Mauviel A
World J Gastroenterol; 2007 Jun; 13(22):3056-62. PubMed ID: 17589920
[TBL] [Abstract][Full Text] [Related]
60. Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.
Lee YH; Schiemann WP
Breast Cancer Manag; 2014; 3(1):73-85. PubMed ID: 25904986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
